TCT-60 Clinical Outcome of Preventive Angioplasty in ST-elevation Myocardial Infarction  by Park, Hyun Woo et al.
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comTCT-60
Clinical Outcome of Preventive Angioplasty in ST-elevation Myocardial
Infarction
Hyun Woo Park1, HEE SOON PARK1, Se Hun Kang1, Sang Soo Cheon1,
Byeong Joo Bae1, Min Su Kim1, Jae Hyung Roh1, Jung-Min Ahn1, Mineok Chang1,
Sung-Han Yoon1, Jong-Young Lee1, Duk-Woo Park1, Soo-Jin Kang1,
Seung-Whan Lee1, Young-Hak Kim1, Cheol Whan Lee1, Seong-Wook Park1,
Seung-Jung Park1
1Asan Medical Center, Seoul, Korea, Republic of
Background: The aim of this study was to evaluate the clinical outcome of preventive
angioplasty in ST-elevation Myocardial Infarction.
Methods: From the IRIS-DES registry, we identiﬁed 683 patients treated using stent
with ST-elevation myocardial infarction (STEMI) who had multivessel disease. A
total 212 patients was underwent infarct-artery percutaneous coronary intervention
(PCI) alone, and a 471 patients was underwent preventive PCI. Major adverse cardiac
events (MACE) were deﬁned using composite of death, myocardial infarction, and
target vessel revasularization (TVR).
Results: During 2 years follow up, culprit only PCI versus preventive PCI was no
signiﬁcant difference in MACE cumulative incidence(11.4% vs 12.5%, Hazard ratio
[HR], 95% conﬁdence interval [CI] 0.89 (0.55 – 1.45), P ¼ 0.652), death (6.0% vs
7.1%, 0.86 (0.45 – 1.65), P ¼ 0.653), MI (1.6% vs 7.1%, 1.11 (0.27 – 4.60), P ¼
0.876), and TVR (8.5% vs 12.0%, 0.65 (0.38 – 1.12), P ¼ 0.121). The cumulative
rates of Academic Research Consortium deﬁned deﬁnite stent thrombosis were 1.0%
in Only culprit PCI group and 0.9% in preventive PCI group (P ¼ 0.901).
Conclusions: In our registry study, the preventive PCI in STEMI was not associated
with the improvement of clinical outcome, including death, MI, and TVR. A pre-
ventive angioplasty strategy of nonculprit lesions in STEMI remains controversial.B18 JACC Vol 64/11/Suppl B jTCT-61
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Background: Female gender is believed to be a signiﬁcant risk factor for mortality
among patients with ST-segment myocardial infarction (STEMI) undergoing primary
angioplasty (PPCI), but the results of previous studies are controversial.
Methods: We collected data about all consecutive patients with STEMI within 12
hours who underwent PPCI and compared clinical and procedural characteristics as
well as 30-day mortality between males and females.
Results: Between September 2001 and June 2010 1251 patients underwent PPCI at
our hospital. Twenty-ﬁve percent of the cohort (313 patients) was females. Compared
with men, females were less smokers (24.9% vs 75.7%, p< 0.0001), more diabetic
(32.4% vs 24%, p< 0.0001), more hypertensive (77.3% vs 65.8%, p< 0.0001), had a
higher symptoms-to-balloon time (291222 vs 238.5196 min, p< 0.0001), a lower
left ventricular ejection fraction (LVEF) (46.810% vs 48.510%, p¼0.007) and a
lower left main disease (3.8% vs 5.1%, p< 0.0001). Furthermore, females were less
likely to be treated with GP IIb-IIIa inhibitors (76% vs 85.8%, p< 0.0001), with
thrombus aspiration devices (42.4% vs 57.3%, p< 0.0001) and to receive a stent
(81.1% vs 88.4%, p ¼ 0.002). At 30 days, female gender was associated with a higher
mortality (11.8% vs 5.5%, p< 0.0001) and a higher rate of bleedings (4.5% vs 1.4%,
p¼0.002). After propensity score adjustment, female gender continues to be signiﬁ-
cantly associated with a higher 30-day mortality (OR 0.56; CI 95% 0.34-0.93,
p¼0.027).
Conclusions: In STEMI patients undergoing PPCI, female gender had more bleeding
complications and a higher 30-day mortality compared to men, and remained
signiﬁcantly associated to a higher 30-day mortality after correction for baseline
clinical differences. Our data suggest the hypothesis that biological gender-related
differences could, in part, explain these ﬁndings.
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Background: Conﬂicting data exist regarding potential treatment delays and
outcomes for primary percutaneous coronary intervention (pPCI) performed
during off hours. Objective: evaluate the association between off-hour pPCI,
total ischemic time and outcomes in STEMI patients undergoing pPCI in daily
practice.
Methods: 190 consecutive patients (78.9 % men, mean age 62 years  13.8)
with STEMI undergoing pPCI in our University Hospital were prospectively
included from September 2012 to December 2013. Patients were divided in two
groups according to the time of day when pPCI was performed. On-hour pPCI
(Group 1) was deﬁned as pPCI occurring from 8 am to 3 pm and off-hour PCI
(Group 2) was deﬁned as occurring from 3 pm to 8 am. Demographic and
clinical characteristics, ischemic time (lag time between onset of symptoms and
ﬁrst medical contact and door-to-balloon time), acute stent thrombosis, rein-
farction, major vascular complications, stroke and in-hospital mortality were
evaluated.
Results: Off-hours pPCI occurred in 65.2% of patients. There was no statistic dif-
ference in basal characteristics: age > 70 years (1: 31.2% vs. 2: 28.6%, p¼0.41), sex
male (1: 75% vs. 2: 81,7%, p¼0.19), diabetes (1: 32.8% vs. 2: 26.9%, p¼0.26),
hypertension (1: 56.2% vs. 2: 44.5%, p¼0.09) between the two groups. Patients with
symptom onset during working hours had a longer time to ﬁrst medical contact
(136.22  125.05 min) compared with out-of-hours onset (106.67  116.23 min). Lag
time between onset of symptoms and ﬁrst medical contact > 60 min was detected in
64.8% in the on-hour group compared to the 50.4% off-hour group (p¼0.05). Door-to-
balloon time (D2B) > 90 min was also more frequent in patients who underwent pPCI
on-hour (43.6%) compared to off-hour (14.8%) (p< 0.001). Acute stent thrombosis (1:
1.6% vs. 2: 0.8%, p¼0.58), reinfarction (1: 1.6% vs. 2: 2.5%, p¼0.57), major vascular
complications (1: 7.8% vs. 2: 10.1%, p¼0.41), stroke (1: 3.1% vs. 2: 0.8%, p¼0.28)
and in-hospital mortality (1: 4.7% vs. 2: 5%, p¼0.62) were similar between both
groups.
Conclusions: In STEMI patients, off-hour pPCI was common. Short-term clinical
outcomes were similar despite longer ischemic time in patients undergoing on-hour
pPCI.September 13–17, 2014 j TCT Abstracts/Acute Myocardial Infarction
